Analysis of anaphylaxis cases after vaccination: 10-year review from the national vaccine injury compensation program

Annals of Allergy, Asthma and Immunology

Volumn 106, Issue 5, 2011, Pages 440-443

  Johann Liang, Rosemary ^a   Josephs, Shelby ^b   Dreskin, Stephen C ^c  

^a U S DEPARTMENT OF HEALTH AND HUMAN SERVICES   (United States)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; DIPHTHERIA TETANUS TOXOID; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS A VACCINE; HEPATITIS B VACCINE; IMMUNOGLOBULIN E; INFLUENZA VACCINE; MEASLES MUMPS RUBELLA VACCINE; MENINGOCOCCUS VACCINE; PNEUMOCOCCUS VACCINE; POLIOMYELITIS VACCINE; TRYPTASE; VARICELLA ZOSTER VACCINE; WART VIRUS VACCINE;

ABDOMINAL PAIN; ABNORMAL RESPIRATORY SOUND; ADULT; ADVERSE OUTCOME; AGED; AIRWAY OBSTRUCTION; ANAPHYLAXIS; APNEA; BREATHING DISORDER; CAUSAL ATTRIBUTION; CAUSE OF DEATH; CHEST TIGHTNESS; CHILD; CLINICAL ARTICLE; CONSCIOUSNESS DISORDER; COUGHING; CYANOSIS; DIAPHORESIS; DIZZINESS; DRUG EFFECT; DRUG SAFETY; DYSPNEA; ENZYME BLOOD LEVEL; EPISTAXIS; ERYTHEMA; FACE EDEMA; FEMALE; FOOT DISEASE; HAND PARESTHESIA; HEADACHE; HEART DISEASE; HOT FLUSH; HUMAN; HYPOTENSION; INFANT; INJECTION SITE REACTION; LETTER; MALE; NAUSEA; PRESCHOOL CHILD; PRIORITY JOURNAL; PRURITUS; RASH; RESPIRATORY ARREST; RESPIRATORY DISTRESS; SENSORY DYSFUNCTION; SHOCK; SIDE EFFECT; SINUS TACHYCARDIA; SORE THROAT; SWELLING; THROAT DISEASE; THROAT TIGHTNESS; TONGUE SWELLING; TREATMENT OUTCOME; URTICARIA; VACCINATION; VACCINATION REACTION; WHEEZING;

ANAPHYLAXIS; COMPENSATION AND REDRESS; DATABASES, FACTUAL; HUMANS; NATIONAL HEALTH PROGRAMS; TIME FACTORS; VACCINATION;

EID: 79955623926     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/j.anai.2011.01.014     Document Type: Letter

References (7)

1. National Vaccine Injury Compensation Program, Vaccine Injury Table. http:// www.hrsa.gov/vaccinecompensation/table.htm. Accessed October 12, 2010.
2. Somsak JG, Johann-Liang R. Charge to the Committee. http://www8. nationalacademies.org/cp/meetingview.aspx?MeetingID=3398&MeetingNo=1. Accessed October 12, 2010.
3. Ruggeberg JU, Gold MS, Bayas JM, et al. Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine. 2007;25:5675-5684. (Pubitemid 47049764)
4. National Vaccine Injury Compensation Program, Statistics Reports. http:// www.hrsa.gov/vaccinecompensation/statistics-report.htm. Accessed October 12, 2010.
5. Payne V, Kam PC. Mast cell tryptase: a review of its physiology and clinical significance. Anaesthesia. 2004;59:695-703. (Pubitemid 38997011)
6. Pool V, Braun MM, Kelso JM, et al. Prevalence of anti-gelatin IGE antibodies in people with anaphylaxis after measles-mumps rubella vaccine in the United States. Pediatrics. 2002;110:e71.
7. Bohlke K, Davie RL, Marcy SM, et al. Risk of anaphylaxis after vaccination of children and adolescents. Pediatrics. 2003;112:815-820. (Pubitemid 37248689)